Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00368329
What this trial is testing

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsCarcinoma, Squamous CellAdenocarcinoma+1 more
Stanford University 4
Post-approval studies (Phase 4)UnknownNCT05067153
What this trial is testing

Thromboprophylaxis in Oesophageal Cancer Patients

Who this might be right for
Esophageal NeoplasmsThrombosisThromboembolism
University of Aarhus 100
Not applicableLooking for participantsNCT05952661
What this trial is testing

Minimally Residual of Esophageal Cancer 001

Who this might be right for
Esophageal CarcinomaMinimal Residual Disease
Hebei Medical University Fourth Hospital 56
Testing effectiveness (Phase 2)Study completedNCT03985046
What this trial is testing

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 75
Not applicableLooking for participantsNCT07322627
What this trial is testing

ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients

Who this might be right for
Esophageal Cancer
National Taiwan University Hospital 700
Testing effectiveness (Phase 2)UnknownNCT05469061
What this trial is testing

Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaLocally Advanced Carcinoma
The First Affiliated Hospital with Nanjing Medical University 17
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Not applicableStudy completedNCT06895551
What this trial is testing

Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection

Who this might be right for
Esophageal Cancer
Singlera Genomics Inc. 1,069
Testing effectiveness (Phase 2)Study completedNCT00316862
What this trial is testing

Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 82
Not applicableEnded earlyNCT06317272
What this trial is testing

BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
University Medical Center Groningen 1
Testing effectiveness (Phase 2)Study completedNCT04704154
What this trial is testing

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Who this might be right for
Solid Tumors
Bayer 175
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Testing effectiveness (Phase 2)Looking for participantsNCT06603402
What this trial is testing

Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Immunotherapy
Sichuan University 41
Testing effectiveness (Phase 2)Study completedNCT00165490
What this trial is testing

Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer

Who this might be right for
Adenocarcinoma of EsophagusSquamous Cell Carcinoma of Esophagus
Dana-Farber Cancer Institute 19
Not applicableStudy completedNCT00003321
What this trial is testing

Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 370
Large-scale testing (Phase 3)Ended earlyNCT02551458
What this trial is testing

Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy

Who this might be right for
Epidermoid Carcinoma orAdenocarcinoma of the Thoracic Oesophagus orAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)+1 more
Centre Hospitalier Universitaire Dijon 188
Not applicableUnknownNCT03727126
What this trial is testing

Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer

Who this might be right for
Esophageal Cancer
GEM Hospital & Research Center 40
Testing effectiveness (Phase 2)Study completedNCT01059643
What this trial is testing

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Ovarian CancerNon Small Cell Lung CancerProstate Cancer+4 more
Eli Lilly and Company 103
Testing effectiveness (Phase 2)Study completedNCT03989115
What this trial is testing

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Who this might be right for
Solid Tumor
Revolution Medicines, Inc. 113
Next Page